For­get RNA drugs. Ac­cent gets $40M to de­vel­op small mol­e­cules that mod­i­fy RNA in­stead

A Cam­bridge start­up is step­ping out to­day with some rev­e­la­tions on how pro­teins tweak RNA — and sub­se­quent­ly how a cell’s char­ac­ter and func­tion is de­ter­mined …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER